Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ASX/TLX stock hub

ASX/TLX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/TLXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/TLX

In the news

Latest news · ASX/TLX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E530.1

P25 12.9P50 20.4P75 41.2

Trailing P/En/a

P25 14.2P50 19.2P75 35.1

ROE-1.9

P25 -118.7P50 -49.4P75 -1.2

ROIC2.6

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/TLX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

193

Groups with data

Currency

USD

Showing 193 of 193 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Employees	1,184
Employees Change	950%
Employees Change Percent	406
Enterprise value	AUD 5.5B
Exchange	Australian Securities Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	AU000000TLX2
Last refreshed	2026-05-10
Market cap	AUD 5B
Price	AUD 14.75
Price currency	AUD
Rev Per Employee	1,046,048.58x
Sector	Healthcare
Sic	2836
Symbol	asx/TLX
Website	https://telixpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.21%
EV Earnings	-513.91x
EV/EBIT	189.85x
EV/EBITDA	91x
EV/FCF	-85.18x
EV/Sales	4.56x
FCF yield	-1.29%
Forward P/E	530.13x
P/B ratio	8.03x
P/S ratio	4.15x
PE Ratio3 Y	496.87x
PE Ratio5 Y	409x
PEG ratio	14.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.4%
EBITDA Margin	4.04%
Gross margin	47.51%
Gross Profit	AUD 572.5M
Gross Profit Growth	6.58%
Gross Profit Growth Q	12.51%
Gross Profit Growth3 Y	13.37%
Gross Profit Growth5 Y	21.56%
Net Income	AUD -10.7M
Net Income Growth Years	0%
Pretax Margin	-0.66%
Profit Margin	-0.89%
Profit Per Employee	AUD -9,272
ROA	1.15
Roa5y	-9.35
ROCE	2.07
ROE	-1.85
Roe5y	-86.68
ROIC	2.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-45.59%
Cagr3y	10.47%
Cagr5y	30.22%
EPS Growth Years	0
Revenue Growth	55.61x
Revenue Growth Q	49.29x
Revenue Growth Quarters	3x
Revenue Growth Years	7x
Revenue Growth3 Y	23.42x
Revenue Growth5 Y	27.61x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 0.76
Assets	AUD 1.7B
Cash	AUD 212.7M
Current Assets	AUD 455.5M
Current Liabilities	AUD 319.4M
Debt	AUD 700.3M
Debt EBITDA	AUD 11.61
Debt Equity	AUD 1.12
Debt FCF	AUD -10.87
Equity	AUD 622.7M
Interest Coverage	1.4
Liabilities	AUD 1.1B
Long Term Assets	AUD 1.3B
Long Term Liabilities	AUD 802.9M
Net Cash	AUD -487.6M
Net Cash By Market Cap	AUD -9.75
Net Debt EBITDA	AUD 10.02
Net Debt Equity	AUD 0.78
Tangible Book Value	AUD -266M
Tangible Book Value Per Share	AUD -0.79
WACC	7.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.43
Inventory Turnover	13.9
Net Working Capital	AUD -36.8M
Quick ratio	1.21
Working Capital	AUD 147.9M
Working Capital Turnover	AUD 5.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-45.57%
200-day SMA	13.93
3Y total return	34.83%
50-day SMA	13.16
50-day SMA vs 200-day SMA	50under200
5Y total return	274.37%
All Time High	31.97
All Time High Change	-53.86%
All Time High Date	2025-02-26
All Time Low	0.46
All Time Low Change	3,106.52%
All Time Low Date	2018-02-20
ATR	0.63
Beta	0.65
Beta1y	-0.19
Beta2y	0.5
Ch YTD	31.7
High	14.75
High52	27.58
High52 Date	2025-05-08
High52ch	-46.89%
Low	14.41
Low52	8.26
Low52 Date	2026-02-17
Low52ch	78.57%
Ma50ch	12.12%
Price vs 200-day SMA	5.89%
RSI	54.09
RSI Monthly	46.67
RSI Weekly	54.44
Sharpe ratio	-0.66x
Sortino ratio	-0.84
Total Return	2.12%
Tr YTD	31.7
Tr1m	8.62%
Tr1w	-5.27%
Tr3m	49.75%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD 28.9M
Operating Income Growth	-45.24
Operating Income Growth Q	-69.28
Operating Income Growth3 Y	-23.84
Operating Income Growth5 Y	7.32
Operating margin	2.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	272,834,866%
Net Borrowing	-7,622,396.2
Shares Insiders	14.9%
Shares Institutions	46.53%
Shares Out	339,113,888
Shares Qo Q	0.4%
Shares Yo Y	-2.12%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	AUD -93.5M
Average Volume	2,544,290.5x
Bv Per Share	1.84
CAPEX	AUD -38.5M
Ch1m	8.62
Ch1w	-5.27
Ch1y	-45.57
Ch3m	49.75
Ch3y	34.83
Ch5y	274.4
Ch6m	-1.73
Change	-2.25%
Change From Open	0.27
Close	15.09
Days Gap	-2.52
Depreciation Amortization	18,167,147.8
Dollar Volume	14,166,637.5
Earnings Date	2026-08-19
EBIT	AUD 28.9M
EBITDA	AUD 48.7M
EPS	AUD -0.03
F Score	2
FCF	AUD -64.4M
FCF EV Yield	-1.17x
FCF Per Share	AUD -0.19
Financing CF	-5,575,525
Fiscal Year End	December
Founded	2,015
Goodwill	274,428,330.6
Income Tax	AUD 2.8M
Investing CF	-428,652,763
Is Primary Listing	1
Last Earnings Date	2026-02-19
Last Report Date	2025-12-31
Ma150	13.07
Ma150ch	12.85%
Ma20	14.98
Ma20ch	-1.55%
Net CF	-446,960,994
Next Earnings Date	2026-08-19
Open	14.71
Position In Range	100
Ppne	159,441,442.3
Price Date	2026-05-08
Price EBITDA	AUD 103
Relative Volume	0.36x
Revenue	1,205,047,965x
SBC By Revenue	2.41x
Share Based Comp	29,009,520
Tax By Revenue	0.23x
Tr6m	-1.73%
Volume	960,450
Z Score	4.4

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ASX/TLX pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/TLX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/TLX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+46.5%

Share of float held by funds and institutions

Insider ownership

+14.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-2.1%

Negative means the company is buying back shares.

Technical

ASX/TLX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.1

Neutral momentum band

Price vs 200-day MA

+5.9%

50/200-day relationship not available

Beta (5Y)

0.65

Less volatile than the market

Sharpe ratio

-0.66

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/TLX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/TLX stock rating?

asx/TLX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/TLX analysis?

The full report lives at /stocks/asx/TLX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/TLX?

The latest report frames asx/TLX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/TLX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.